Diabetic Paw Syndrome, Diagnostic and Treatment Technologies
Abstract
In terms of the number of diseases most prevalent worldwide, diabetes mellitus ranks third after cardiovascular and malignant tumors (cancer). 30-70% of patients with diabetes worldwide have diabetic foot syndrome. Our article examined 45 patients with type 2 diabetes mellitus who received inpatient treatment in Samarkand City Medical Association and Samdtu multidisciplinary clinic with purulent-necrotic complications. According to our preliminary scientific studies, the most optimal method, which leads to more rapid clearance of the wound from necrotic tissues and reduce the average duration of treatment in hospital, is the use of ascorbic fluid in local and complex surgical treatment of purulent-necrotic soft tissue wounds in diabetic patients.
References
2. Koreiba K.A. Modern drugs of complex action as an alternative to staged necrectomies in purulent-septic surgery. Acerbin. Collection of materials about the drug. Moscow:2018. С-28-33.
3. Svetukhin A.M., Amiraslanov Yu.A. Purulent surgery: current state of the problem. (In the book "50 lectures on surgery" ed. by Saveliev V.S. M-2004. p. 752)
4. Surgical skin and soft tissue infections. Russian national guidelines.Under the recommendation of V.S. Savelyev, 2009- 92p.
5. Shlyapnikov S.A. Surgical infections of soft tissues - an old problem in a new light. Infections in surgery. 2003 -14-21 с.
6. Wagner F.W. Classification and treatment program for diabetic, neuropathic, and dysvascular foot disease. In American Academy of Orthopaedic Surgeons Lecture Course. St. Louis: Mosby Vear Book. 1997: 143-165.